TY - JOUR
T1 - WHO 1st consultation on the development of a global biodosimetry laboratories network for radiation emergencies (BioDoseNet)
AU - Blakely, William F.
AU - Carr, Zhanat
AU - Chu, May Chin May
AU - Dayal-Drager, Renu
AU - Fujimoto, Kenzo
AU - Hopmeir, Michael
AU - Kulka, Ulrike
AU - Lillis-Hearne, Patricia
AU - Livingston, Gordon K.
AU - Lloyd, David C.
AU - Maznyk, Natalie
AU - Perez, Maria Del Rosario
AU - Romm, Horst
AU - Takashima, Yoshio
AU - Voisin, Phillipe
AU - Wilkins, Ruth C.
AU - Yoshida, Mitsuaki A.
PY - 2009/1
Y1 - 2009/1
N2 - The World Health Organization (WHO) held a consultation meeting at WHO Headquarters, Geneva, Switzerland, December 17-18, 2007, to develop the framework for a global bio- dosimetry network. The WHO network is envisioned to enable dose assessment using multiple methods [cytogenetics, electron paramagnetic resonance (EPR), radionuclide bioassays, etc.]; however, the initial discussion focused on the cytogenetic bioassay (i.e., metaphase-spread dicentric assay). Few regional cytogenetic biodosimetry networks have been established so far. The roles and resources available from United Nations (UN) agencies that provide international cooperation in biological dosimetry after radiological emergencies were reviewed. In addition, extensive reliance on the use of the relevant International Standards Organization (ISO) standards was emphasized. The results of a WHO survey of global cy- togenetic biological dosimetry capability were reported, and while the survey indicates robust global capability, there was also a clear lack of global leadership and coordination. The expert group, which had a concentrated focus on cytogenetic biodosimetry, formulated the general scope and concept of operations for the development of a WHO global biodosime- try laboratory network for radiation emergencies (Bio-DoseNet). Follow-on meetings are planned to further develop technical details for this network.
AB - The World Health Organization (WHO) held a consultation meeting at WHO Headquarters, Geneva, Switzerland, December 17-18, 2007, to develop the framework for a global bio- dosimetry network. The WHO network is envisioned to enable dose assessment using multiple methods [cytogenetics, electron paramagnetic resonance (EPR), radionuclide bioassays, etc.]; however, the initial discussion focused on the cytogenetic bioassay (i.e., metaphase-spread dicentric assay). Few regional cytogenetic biodosimetry networks have been established so far. The roles and resources available from United Nations (UN) agencies that provide international cooperation in biological dosimetry after radiological emergencies were reviewed. In addition, extensive reliance on the use of the relevant International Standards Organization (ISO) standards was emphasized. The results of a WHO survey of global cy- togenetic biological dosimetry capability were reported, and while the survey indicates robust global capability, there was also a clear lack of global leadership and coordination. The expert group, which had a concentrated focus on cytogenetic biodosimetry, formulated the general scope and concept of operations for the development of a WHO global biodosime- try laboratory network for radiation emergencies (Bio-DoseNet). Follow-on meetings are planned to further develop technical details for this network.
UR - http://www.scopus.com/inward/record.url?scp=58349097924&partnerID=8YFLogxK
U2 - 10.1667/RR1549.1
DO - 10.1667/RR1549.1
M3 - Article
C2 - 19138057
AN - SCOPUS:58349097924
SN - 0033-7587
VL - 171
SP - 127
EP - 139
JO - Radiation Research
JF - Radiation Research
IS - 1
ER -